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Abstract
Medicinal plants are being explored as natural inhibitors of HMG-CoA reductase (vital enzyme in
cholesterol biosynthesis) as the drugs (statins), used in the management of hypercholesterolemia,
are associated with side effects. In this study, medicinal plants: Abrus precatorius Linn. (AP),
Canthium parviflorum Lam. (CP) and Costus speciosus (Koenig)Sm. (CS) were studied for
phytochemical composition and the ability of  methanol extract (300 g) to inhibit HMG-CoA
reductase activity, using HMG-CoA as a substrate. The assay is based on the stoichiometric formation
of Coenzyme A during the reduction of microsomal HMG-CoA to mevalonate. Phytochemicals
glutathione, tannins, alkaloids and vitamin C were at higher amount in AP, CP and was rich in
flavonoids and  tocopherol and polyphenols, -carotene, saponins and steroidal saponins presence
was indicated in CS. The plants showed varying degree of inhibition of HMG-CoA reductase. The
CoA released at the end of assay in the control (119.70 nM) and statins (94.46 nM) was higher than
that released in systems, containing CS (72.97 nM) > CP (55.41 nM) >AP (50.23 nM) extracts.
From the results, it can be concluded that all the three plants studied possess HMG-CoA reductase
inhibitory activity, indicating scope for their utilization as cholesterol lowering agents. However,
further studies are needed, before recommending them as safe therapeutic agents.
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1.  Introduction
In current times, there is a great deal of interest in the use of herbal
remedies for human ailments. The use of these remedies is based on
the fact that these medicines contain a large amount of natural
substances which alleviate illness, thus, promoting health. World
Health Organization (WHO) reported that more than 80% of the
world population depends on traditional medicines for primary
healthcare and they utilize the plant extracts or bioactive components
present in them (Levy and Brink, 2005).
Epidemiological studies have indicated that hypercholesterolemia
confers high risk for atherosclerosis and occlusive related vascular
disorders which still occurs increasingly and accounts for the
majority of mortality worldwide (NIHCE, 2008). Elevated
cholesterol levels are treated with a diet, consisting of low saturated
fat, trans fat-free, low cholesterol foods, often followed by one of
various hypolipidemic  agents,  such  as statins, fibrates,  cholesterol
absorption inhibitors, nicotinic acid derivatives or bile acid
sequestrants (Rudney et al., 1981).  . Since these cholesterol lowering
drugs are associated with some side effects, medicinal plants are
being explored as natural hypocholesterolemic agents  (Reddy
et al., 2012).
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The enzyme HMG-CoA reductase plays a vital role in the de novo
cholesterol  synthesis, by catalyzing the conversion of 3-hydroxy-
3-methylglutaryl-CoA (HMG-CoA) to mevalonate, a rate limiting
step. Inhibition of HMG-CoA reductase alters the synthesis of
cholesterol, proving beneficial in hypercholesterolemic condition
(Reddy et al., 2012).
Several medicinal plants such as Moringa oleifera (Ghasi et al.,
2000),   Terminalia arjuna  (Gupta et al., 2001),  Sushruta Samhita
(Shields and Moranvillie, 2005), Trigonella foenum-graecum
(Sowmya aand Rajyalakshmi, 1999), Alfaalfa   (Malinow et al.,
1980) etc., have been extensively studied for their cholesterol
lowering effects. Our team has explored the lipid lowering and
antioxidant potential of Moringa oleifera and Morus indica using
in vitro, ex vivo and animal models (Urooj and Reddy, 2010; Oinum
et al., 2012; Arabshahi-Delouee and  Urooj 2007; Reddy and Urooj,
2013). Western Ghats of Karnataka, South India is abundant in
medicinal plants, having several health benefits. Three plants: Abrus
precatorius (AP), Canthium parviflorum (CP) and Costus speciosus
(CS) (Arabshahi-Delouee and Urooj., 2007) found in this region
have been explored for their medicinal properties. Abrus precatorius
has been studied for its anti-inflammatory (Kuo, 1995);  anticancer
(Sujit et al., 2011) and Canthium parviflorum is reported for its
antioxidant capacity ( Baskar et al., 2008), wound healing and as a
diuretic (Mohidin et al., 2003) and antimicrobial agent  (Peter
et al.,2011)   well documented for its antidiabetic (Srivastava, 2011)
and hepatoprotective (Verma and Khosa, 2009) effects. However,
there are no reports on the hypocholesterolemic potency of these
plants.
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Hence, these medicinal plants namely: Abrus precatorius (AP),
Canthium parviflorum (CP) and Costus speciosus (CS) were studied
for the HMG-CoA reductase inhibitory effect, using an ex vivo
assay and compared with statins.
2.  Materials and Methods
Three medicinal plants: Abrus precatorius Linn. (AP), Canthium
parviflorum Lam. (CP) and Costus speciosus (Koenig)Sm (CS)
were collected from the Western Ghats of Karnataka, identified by
Dr. Janardhan, Department of Studies in Botany, University of
Mysore and voucher specimen was retained in the laboratory for
future.
2.1  Preparation of the samples
The leaves were washed and dried in a hot air oven at 60°C for
8-10 hrs. The dried samples were ground into a fine powder, sieved
through a 60mm mesh and stored in air tight containers at 4ºC until
further use.
2.2  Estimation of phytochemicals
The dehydrated sample was assayed for phytochemical
components, using standard methods. Total phenols were extracted
from a weighed portion (50-500 mg) of dried sample with 5 ml of
1.2M HCl in 50% aqueous methanol for 2 h and analyzed by Folin-
Ciocalteu micro method. Results are expressed as µmol gallic acid
equivalent g-1dry weight. Flavonoids were determined by a
pharmacopoeia method, using Rutin as a reference compound,
alkaloids by the method based on the reaction with bromocresol
green (BCG), using Atropine as a standard, saponins by using
vanillin and sulfuric acid reagents and Diosgenin as standard, tannins
estimated by Folin-Ciocalteu micro method, -tocopherol was
extracted by direct saponification of dried sample and estimated
based on formation of a red complex from reaction of   bipyridyl
with ferrous ion due to reduction of ferric ion by tocopherol .
-carotene was quantified by column chromatography, followed
by measuring the absorbance of elute at 450 nm against standard
-carotene. Reduced glutathione was determined based on the
development of a yellow compound due to reaction of 5,5-Dithio
(bis) nitro benzoic acid (DTNB) with compounds containing
sulphydryll groups (Reddy and Urooj, 2013).
2.3  Preparation of extract
Fifteen grams sample was extracted with 100 ml methanol, in a
mechanical shaker for 6 hrs. The extracts were evaporated at 40ºC
under reduced pressure to dryness in a rotary evaporator (Superfit,
India). The extract was further dried and stored in air-tight container
at 0ºC until used.
2.4  Preparation of microsomes
A healthy male adult rat was obtained from the Central animal
house, Department of Zoology, University of Mysore, after availing
clearance from the University Animal Ethics Committee of
University of Mysore (No. MGZ/2620/2011-12; dated:
31.01.2012). The rat was fasted 24 hrs and sacrificed after 9:00 pm
to obtain the active HMG-CoA reductase enzyme. The liver was
immediately removed from the rat and placed in cold triethanolamine
HCl buffer (0-4°C) at pH 7.4. The liver was thoroughly chilled and
homogenized. The homogenate was centrifuged at 60,000 g for 60
min, the supernatant was separated and microsomal pellet was
then rinsed with buffer and frozen at -20° C. The resuspended
microsomes to be used for the assay were diluted with buffer to give a
protein concentration of 5-10 mg/ml. The procedure described here is
partially modified from that reported by Shapiro and Rodwell (1971).
2.5  3-Hydroxy-3-methylglutaryl CoA reductase assay
For the assay of 3-hydroxy-3-methylglutaryl CoA reductase, the
incubation mixtures contain 0.5-1.0 mg of microsomal protein, 150
nmoles of HMG- CoA, and 2ìmoles of NADPH. These components
are added to 0.8 ml of 0.1 M triethanolamine-0.02 M EDTA buffer
at pH 7.4 without dithiothreitol. The dithiothreitol (0.2 mole)
was added along with the microsomal preparation. The final
incubation volume was 1 ml. contents in tubes were as follows: (a)
All components, (b) all components except NADPH, (c) all
components  except  NADPH with  300  µg  of AP,  CP  and  CS
methanol extracts separately, and (d) all components except NADPH
with statins (Frankel et al., 1973). After a series of steps, the







The 1.43 is the dilution factor, and A is the absorbance at 412 nm.
The difference in absorbance between the complete reaction and
that of all components except NADPH represents the activity due
to HMG-CoA reductase.
2.6  Statistical analysis




Table 1 depicts the phytochemical composition of the three samples:
AP, CP and CS. The glutathione (375±176.77 mM), tannins
(1160±0.076 mg), alkaloids (1100.0±0.03 mg) and vitamin C (Fresh
basis-0.443±0.011 g; dry basis-0.643±0.04 g) was highest in AP,
the flavonoids (2.443±0.811 mg) and -tocopherol (164.6±22.1
mg) content was  high in CP, and CS was rich in polyphenols
(3.211±0.121 g), -carotene (1377.3±2.51 mg), saponins
(0.282±0.04 mg)and steroidal saponins (0.238±0.038 mg)
respectively.
3.2  3-Hydroxy-3-methylglutaryl CoA reductase assay
Liver microsomes were treated with methanol extracts (300 µg) of
the three plants and their effect on the activity of 3-hydroxy-3-
methyl glutaryl CoA reductase was measured based on the
coenzyme A released during the reduction of 3- hydroxy-3-
methylglutaryl CoA to mevalonate. The assay was run against a
control and compared with the statins. The results indicate that all
the three samples were highly effective (51-66 %) compared to
statins (37 %) in inhibiting the HMG-CoA reductase in the liver
microsomes (Figure 1).
The Coenzyme A released during the assay was higher in control
(119.7 nmoles) than the microsomes treated with AP, CP, CS and
statins (Figures 2 and 3) and among all, Abrus (AP) was more
potent in inhibiting the enzyme activity (50.23 nmoles).  Figure 2
shows the time course of activity of HMG CoA reductase for a
period of 4 min. From the Figure, it can be observed that the rate of
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release of Coenzyme A was constantly increasing from zero to 4th
min, both in control and statins. The Co enzyme A released at the
zero min. was low in statins (36.54 n moles) than the other samples
and control. The rate of release of Co enzyme increased rapidly at
0.5th min in statins (57.14 n moles) and was higher than that of AP
(47.52 n moles) and CP (49.62 n moles). At the end of the 4 th
minute, the Co enzyme A released in  the presence of AP (50.23 n
moles), CP (55.41 n moles) and CS (72.97 n moles) was lower than
that of  statins (94.46 n moles).
Figure 3 shows the total HMG Co A reductase activity as nmoles
of Coenzyme A released at the end of 4th min in the following order:
control (119.7 n moles) > statins (94.46 n moles) > CS (72.97 n
moles) > CP (55.41n moles) > AP (50.23nmoles). No significant
(p<0.05) difference was observed between the Co enzyme A released
by AP and CP.  The low amount of CoA released by three medicinal
plants compared to statins is indicative of the inhibitory effect on
HMG- CoA reductase.
  Table 1: Phytochemical composition of selected medicinal plants (g/100 g)
Phytochemicals AP C P C S
Polyphenols 1.06 ± 0.06 1.279 ± 0.32 3.211 ± 0.121
Flavonoids* 1.325 ± 0.085 2.443 ± 0.811 1.174 ± 0.42
Glutathione** 375 ± 176.77 311.55 ± 2 5 285.6 ± 3 3
- Tocopherol *  36.6 ± 3.05 164.6 ± 22.1 90.94 ± 3.29
Tannins * 1160 ± 0.076 605.04 ± 0.025 1088.0 ± 0.036
- carotene *** 1260.0 ± 0.05 1060.0 ± 0.6 1377.3 ± 2.51
Alkaloids * 1100.0 ± 0.03 400.0 ± 0.06 120.0 ± 0.03
Total saponins 0.244 ± 0.01 0.200 ± 0.04 0.282 ± 0.04
Steroidal saponins 0.186 ± 0.028 0.148 ± 0.051 0.238 ± 0.038
Vitamin C (Fresh basis) 0.443 ± 0.011 0.141 ± 0.001 0.135 ± 0.008
Vitamin C ( Dry basis) 0.643 ± 0.04 0.0228 ± 0 0.0237 ± 0.004
AP-Abrus precatorius; CP-Canthium parviflorum; CS-Costus speciosus; *mg/100  g,  **mmol/100g  :  ***  µg/100g  dry  basis:
Values are mean of triplicates
Figure 1: Percent inhibition of HMG CoA reductase by selected medicinal plants (300 g) Ctrl-control; stns-statins; AP-Abrus precatorius;
CP-Canthium parviflorum;CS-Costus speciosus
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Figure 2: Effect of selected medicinal plants on the HMG COA reductase activity and release of CO enzyme A AP-Abrus precatorius;
CP- Canthium parviflorum; CS-Costus speciosus
Figure 3: Total coenzyme A (n moles/mg protein) released during the reduction of   HMG COA to Mevalonate, AP-Abrus precatorius;
CP-Canthium parviflorum; CS-Costus speciosus; (p>0.05)
4.  Discussion
Cholesterol is an insoluble lipid molecule that plays a critical role
in the structure and function of membrane bi-layers. Membrane
cholesterol contents that are either too high or too low are
detrimental to cell function. When present in excess amounts in
cells, cholesterol becomes toxic. Certainly, cholesterol-induced
cytotoxicity represents a key initiating event leading to the
development of atherosclerotic cardiovascular disease (Tabas, 2002).
Statins are the most commonly administered class of drugs to lower
plasma LDL cholesterol. Their primary mechanism of action is to
promote clearance of LDL particles from the plasma. Statins reduce
the rate of intracellular cholesterol synthesis by inhibiting HMG-
CoA reductase, the rate-limiting step in cholesterol biosynthesis
(Brown and Goldstein, 1986).
The enzyme inhibitory effect correlates with the medicinal
properties and phytochemical components such as phenolic
compounds, alkaloids, saponins  etc. Phytochemical analysis revealed
the presence of alkaloids, glutathione, vitamin C and tannins in
higher quantities in Abrus. The phytoconstituents, antioxidant and
antiproliferative activities of various solvent extracts of Abrus has
been reported (Umamaheswari, 2012).  No data is reported for
comparison of present observations.
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Oral administration of Costu signeus leaf powder (500 mg/kg bw)
and Canthium parviflorum   ethanol extract at different
concentrations produced a significant hypoglycaemic effect in
alloxan and STZ- induced diabetic rats. The concurrent effect of
Costus and Canthium on lipid metabolism was significant in diabetic
rats, this was evidenced by the reductions in serum cholesterol,
triglycerides and lipid peroxides (Devi and Urooj, 2008; Purushoth
et al., 2012). However, the mechanism involved in the cholesterol
lowering by Costus and Canthium leaves has not been reported.
The inhibition of Coenzyme A reductase has greater significance in
cholesterol metabolism and, thus, has various health benefits. The
synthetic drug statin along with inhibiting the HMG-CoA also
blocks Coenzyme Q required for energy production and, thus,
impairing cardiac and liver function (Rudney et al., 1981). Several
clinical studies have reported  that the patients with/without
coronary heart disease (CHD), when treated with HMG-CoA
reductase inhibitors and other lipid-lowering drugs like fibrates to
lower plasma cholesterol levels, a reduction in cardiovascular
morbidity and mortality was also seen (Scandinavian, 1994;
Shepherd et al., 1995;  Stael et al., 1998). However, most commercial
HMG-CoA reductase-inhibitors are associated with adverse effects,
including the induction of cutaneous vasodilation, rashes,
gastrointestinal discomfort, hyperuricemia, hyperglycemia and
hepatic dysfunction (Reddy et al., 2012). Hence, the exploitation
of natural remedies in inhibiting the HMG-CoA reductase becomes
very essential.
There are many reports, on the hypocholesterolemic potency of
herbal drugs. Epidemiologic studies have shown a correlation
between an increased consumption of phenolic antioxidants and a
reduced risk of CVD which is supported by a study where the
HMG CoA reductase was inhibited by Moringa oleifera
polyphenols at different concentrations (Reddy and Urooj, 2012).
and supplementation of Moringa leaf polyphenol extract resulted
in a significant decrease in plasma cholesterol in rats fed with high
fat and cholesterol diet.
3-Hydroxy- 3-methylglutaryl Coenzyme A reductase, the enzyme
that synthesizes mevalonate, appears to be regulated through a
multivalent feedback mechanism. Full suppression of the reductase
requires the presence of at least two regulators: cholesterol, which
is normally derived exogenously from plasma low density
lipoprotein (LDL) and a non-sterol product, which is normally
synthesized endogenously from mevalonate (Brown and  Goldstein,
1980).  In cultured mammalian cells such as human fibroblasts, the
activity of HMG CoA reductase, and hence, the formation of
mevalonate is controlled through a feedback mechanism mediated
by cholesterol that enters cells bound to a plasma lipoprotein, low
density lipoprotein (LDL). In the absence of plasma LDL, cells in
culture synthesize their own cholesterol, maintaining high levels of
HMG CoA reductase.  This effect was demonstrated by adding
LDL to the culture medium. The LDL-derived cholesterol reduced
the activity of HMG CoA reductase, thereby turning off the cell’s
cholesterol synthesis (Brown et al., 1973; Brown and Goldstein,
1979). In the present study, the plant extracts and statins might
have acted in a similar manner as LDL in inhibiting HMG CoA
reductase, thus, preventing formation of mevalonate.
Although several medicinal plants have been reported to possess
cholesterol lowering properties, data are  reported on the cholesterol
lowering mechanism (Mohamed et al., 2009; Adaramoye et al.,
2008; Osorio-Esquivel et al., 2012).  The major metabolic pathway
for reducing cholesterol is via conversion to bile acids or preventing
the cholesterol synthesis by inhibiting the HMG CoA reductase
enzyme. To establish the cholesterol lowering mechanism of the
medicinal plants studied, we are also exploring its bile acid binding
capacity using in vitro model system. Such preclinical studies will
help in proper selection of medicinal plants for promoting their
therapeutic utility.
5.  Conclusion
The finding of the present study lends support to the reported data
on the hypocholesterolemic role of Abrus, Canthium and Costus
speciocus by inhibiting the activity of HMG CoA  reductase, a key
enzyme in cholesterol biosynthesis. Abrus, in particular exhibited
maximum inhibition indicating scope for its utilization.  Studies on
the isolation and characterization of pure extracts of these medicinal
plants can result in developing a neutraceutical for  use in functional
food formulations in the management of hypercholesterolemia.
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